Khurram Nasir: Preventive Cardiology Innovation and Scientific Dissemination at ESC 2026
Khurram Nasir, Co-Director Houston Methodist-Rice University Digital Health Institute (HM-Rice DHI) at Houston Methodist, shared on LinkedIn:
“Congratulations to all investigators presenting at ESC 2026. The pace of innovation in cardiovascular prevention continues to accelerate, and the field benefits when high-quality data are translated with clarity and clinical relevance.
At American Journal of Preventive Cardiology, we are excited to consider simultaneous publications aligned with ESC 2026.
For studies that are ready for broad dissemination, we will offer an expedited editorial pathway, with rapid triage and focused peer review designed to preserve scientific standards while matching the timelines of major scientific meetings.
Simultaneous publication helps ensure that important prevention findings reach clinicians, health systems, and guideline stakeholders when attention is highest and decisions are being shaped.
If you would like your ESC 2026 presentation considered for this pathway, please plan to submit by July 24 to allow adequate time for review, revision, and production.”
Stay updated with Hemostasis Today.
-
Aug 27, 2026, 00:04John Cush: Registry Study Confirms Real-World Liver Risks with Avacopan
-
Aug 26, 2026, 23:57N. Mariana S. Vasquez: TTP vs ITP vs DIC
-
Aug 26, 2026, 23:49Mauricio Ambriz: Pathogenesis of Autoimmune Hemolytic Anemia Mediated by Warm and Cold Antibodies
-
Aug 26, 2026, 23:45Can Thromboinflammation Biomarkers Improve PE Mortality Prediction? – RPTH Journal
-
Aug 26, 2026, 23:44From Almost Universally Fatal to Largely Treatable iTTP – American Society of Hematology
-
Aug 26, 2026, 23:39Eric Topol: Shingles Vaccine Associated with 10% Drop in Heart Failure and Stroke
-
Aug 26, 2026, 22:59Debbe McCall: Should Frail Elderly Patients Stable on Warfarin Switch to DOACs?
-
Aug 26, 2026, 18:38Maia Meier: Muhiba’s Story of Courage, Resilience and Hope With Type 3 VWD
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero